Journal of Ocular Pharmacology and Therapeutics · 2006 · 43 citations · 21 references
Ocular DiseaseRetinal Neurological DegenerationPharmacotherapyExperimental PharmacologyRetinaVitreous BodyOphthalmologyBiochemistryNeuropharmacologyCalpain InhibitorsCalpain-mediated ProteolysisPharmacologyAqueous HumourExperimental OphthalmologyDrug DiscoveryPhysiologyGlaucomaMedicineRetinal Penetration
Calpain-mediated proteolysis has been involved in neuronal cell death of retinal neurological degeneration. An aldehyde-based calpain inhibitor, SJA6017 (1), was effective following oral administration in a rat retinal ischemia model but had low oral bioavailability. The aim of this study was to identify calpain inhibitors with good retinal penetration after oral dosing. The orally bioavailable inhibitors, hemiacetal 3 (SNJ-1715), amphipathic ketoamide 5 (SNJ-1945), and pyridine ketoamide 6 (SNJ-2008), were evaluated for their retinal pharmacokinetic (PK) profiles. The retinal drug exposure of these inhibitors was more than tenfold higher than 1. Among these compounds, 5 exhibited the most favorable retinal PK properties, such as good penetration and long half-life. Comparisons of 5 and the structurally related ketoamide 6 suggested that the presence of a methoxy diethylene glycol moiety resulted in the inhibitor with high penetration into the retina and the sustained high retinal levels. Ketoamide 5 was selected as the development candidate for the treatment of retinal diseases.
21
Six-Hour Window of Opportunity for Calpain Inhibition in Focal Cerebral Ischemia in Rats
Carrie G. Markgraf, Nelson L. Velayo, Michael P. Johnson et al. · Stroke · 1998 · 245 citations · Full text
Neuroprotection with a calpain inhibitor in a model of focal cerebral ischemia.
Seung‐Chyul Hong, Yasunobu Goto, Giuseppe Lanzino et al. · Stroke · 1994 · 181 citations · Full text